跳至主要内容
临床试验/NCT03963141
NCT03963141已完成不适用

Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE.

AstraZeneca1 个研究点 分布在 1 个国家目标入组 40,541 人开始时间: 2019年8月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
40,541
试验地点
1
主要终点
Asthma-related Cost

研究概览

简要总结

This Retrospective cohort study with an overall objective of to perform a descriptive analysis of the asthma patient population in the Emirate of Dubai with respect to healthcare resource utilization, costs, and asthma-related treatment patterns and outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Minimum two claims with asthma diagnosis, 30 days apart, during the identification period
  • Minimum 12 months of baseline period
  • Age ≥ 18 years on the index date
  • Continuous enrolment during the baseline period and at least 180 days of follow-up period; enrolment will be defined based on at least one activity during each 90-day period from the index date

排除标准

  • Diagnosis of COPD during the baseline period. Diagnosis of COPD will be defined as ≥1 medical claim with an ICD-10 diagnosis in any position

结局指标

主要结局

Asthma-related Cost

时间窗: 1 Year

Total asthma-related cost reported in the databse during December 2015 through November 2018(summarized annually).It will will be computed in the follow-up period and will be reported as a percentage and number of visits per person per year (PPPY). Utilization will be considered "asthma-related" if the associated medical claim(s) has ICD-10 diagnosis code for asthma as the principal diagnosis

Asthma Patients Number

时间窗: 1 Year

Number of unique asthma patients in the database during December 2015 through November 2018(summarized annually).it will be computed in the follow-up period and will be reported as a percentage and number of visits per person per year (PPPY). Utilization will be considered "all-cause" if the associated medical claim(s) has a diagnosis code in any position for any condition.

次要结局

  • Asthma-related hopitalizations cost(1 Year)
  • Astma-related prescription pattern(1 Year)
  • Severity of Asthma per total number of patients(1 Year)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验